Health
FDA Approves Lipfendra, the First Oral Treatment Designed to Block PCSK9
The U.S. Food and Drug Administration has approved Lipfendra (enlicitide), a once-daily tablet intended to help lower low-density lipoprotein cholesterol, commonly called LDL or “bad” cholesterol. According to […]